Rapid intraoperative assessment of breast excision specimens is clinically important because up to 40% of patients undergoing breast-conserving cancer surgery require reexcision for positive or close margins. We demonstrate nonlinear microscopy (NLM) for the assessment of benign and malignant breast pathologies in fresh surgical specimens. A total of 179 specimens from 50 patients was imaged with NLM using rapid extrinsic nuclear staining with acridine orange and intrinsic second harmonic contrast generation from collagen. Imaging was performed on fresh, intact specimens without the need for fixation, embedding, and sectioning required for conventional histopathology. A visualization method to aid pathological interpretation is presented that maps NLM contrast from two-photon fluorescence and second harmonic signals to features closely resembling histopathology using hematoxylin and eosin staining. Mosaicking is used to overcome trade-offs between resolution and field of view, enabling imaging of subcellular features over square-centimeter specimens. After NLM examination, specimens were processed for standard paraffin-embedded histology using a protocol that coregistered histological sections to NLM images for paired assessment. Blinded NLM reading by three pathologists achieved 95.4% sensitivity and 93.3% specificity, compared with paraffin-embedded histology, for identifying invasive cancer and ductal carcinoma in situ versus benign breast tissue. Interobserver agreement was κ = 0.88 for NLM and κ = 0.89 for histology. These results show that NLM achieves high diagnostic accuracy, can be rapidly performed on unfixed specimens, and is a promising method for intraoperative margin assessment.nonlinear microscopy | breast cancer | pathology | imaging B reast cancer is the most common cancer and cause of cancerrelated death in women worldwide (1). In the United States, one in eight women will develop breast cancer in their lifetimes with an estimated 226,870 new cases and 39,510 deaths in 2012 (2). Breast-conserving therapy (BCT), lumpectomy followed by adjuvant radiation and/or chemotherapy and hormonal therapy, is a standard of care for early breast cancer and achieves survival and local recurrence rates comparable to mastectomy while providing superior cosmetic outcomes and reduced morbidity (3-5). Local recurrence rates are correlated with surgical margin status, which is evaluated using intraoperative examination and postoperative histopathology. However, there is no consensus on surgical margin widths, and differing conventions for negative and close margins have shown inconsistent correlations with therapeutic outcomes (6-9). Despite these inconsistencies, margins initially positive for invasive cancer or ductal carcinoma in situ (DCIS) almost always require surgical reexcision (92.6% when positive for DCIS and 83.5% when positive for invasive cancer) (9), and up to 40% of all women undergoing BCT require repeat surgeries from positive or close margins (10-12). In addition to surgical complications and incr...